Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™ Blog Post
Publication: Journal of Pharmacological and Toxicological Methods Abstract Adverse effects due to off-target activity can be predicted by careful comparison of the relationship between expected plasma concentration and off-target activity of...
Pharmacometrics for Regulatory Submission Support Page
Certara’s team of pharmacometrics consultants, PBPK programmers, regulatory writers, and submission experts can support your regulatory submissions.
Pharmacometrics: Support Early Decision-Making Page
Pharmacometrics Services for Early Drug Development Pharmacometrics services for early drug developmentQuantitative insights to inform key development decisions Learn more about pharmacometrics services for early drug development Connect with an...
Antibody-Drug Conjugate (ADC) Model Pack Page
Assess™ ADC Model Pack includes 42 validated QSP models for monospecific and bispecific antibody-drug conjugates (ADC) with and without avidity.
Protein Degrader Model Pack Page
Assess™ Protein Degrader Model Pack includes validated QSP models for protein degrader pharmacologies like PROTACs and Molecular Glue Degraders.
Avidity Model Pack Page
Assess™ Avidity Model Pack includes validated QSP models covering soluble and membrane ligand pharmacologies, with avidity.
Gene Therapy Model Pack Page
Assess ™ Gene Therapy Model Pack includes 8 validated QSP models covering gene therapies like LNP-encapsulated mRNA and siRNA.
Biotherapeutic Model Pack Page
Assess™ Biotherapeutic Model Pack is a library of monospecific and bispecific, single- and multi-compartment validated QSP models for biotherapeutics.
Cell Engager Model Pack Page
Assess™ Cell Engager Model Pack includes validated QSP models for solid tumors, in vitro experiments, & solid tumors with 2 cell types.
